Core Insights - The signing of seven key projects at the Foshan Yundonghai Pharmaceutical Health Industry Park marks a significant step in the development of the pharmaceutical and health industry in Foshan, with total investments exceeding 1 billion yuan [1][3][6]. Group 1: Event Overview - The high-quality development conference and project signing event was supported by the Guangdong Provincial Department of Industry and Information Technology and the Guangdong Provincial Drug Administration, and organized by the Foshan High-tech Industrial Development Zone Management Committee and Foshan Construction Development Group [2]. - This event signifies Foshan's commitment to cultivating new productive forces and building a biopharmaceutical industry cluster, injecting strong momentum into the high-quality development of the Greater Bay Area's pharmaceutical health industry [2]. Group 2: Project Details - The seven signed projects cover various cutting-edge fields, including biopharmaceuticals, new regenerative medical materials, high-end medical devices, and pharmaceutical packaging materials, with investment sizes ranging from 5 million to 800 million yuan [6]. - The Yundonghai Biological Science Industrial Park project, with a total investment of 800 million yuan, aims to build standard factories and high-tech public service platforms to meet the production needs of biopharmaceutical companies [6]. Group 3: Infrastructure and Services - The Guangdong Provincial Medical Device Quality Supervision and Inspection Institute's Foshan Laboratory was officially launched, serving as a core support for the park's service capabilities [10][12]. - The laboratory, as the only national-level medical device inspection institution in South China, covers four major fields and has the capacity for 338 standards and 2632 project parameters, significantly enhancing the speed of product market entry for local enterprises [11]. Group 4: Policy and Financial Support - The "Support Measures for the High-Quality Development of Yundonghai Pharmaceutical Health Industry Park" was released, offering multiple support measures for ten industry categories, with the highest funding amount reaching 15 million yuan [13]. - Foshan Jianfa Private Equity Fund and Huaxi Yuanyou Venture Capital Fund have reached a cooperation agreement with a total subscription scale exceeding 2.1 billion yuan, focusing on investments in biotechnology and health projects [14]. Group 5: Talent and Future Development - The Guangdong-Hong Kong-Macao Greater Bay Area (Foshan) Talent Service Workstation was inaugurated to provide one-stop services for policy consultation, entrepreneurial support, and talent introduction, enhancing the collaboration between industry, academia, and research [14]. - Foshan has over 3,000 medical and health institutions, a complete manufacturing industry chain, and a favorable business environment, aiming to attract more entrepreneurs to establish themselves in the Yundonghai area and jointly create a trillion-level pharmaceutical health industry cluster [14].